BONE THERAPEUTICSCS S.A.

BONE THERAPEUTICSCS S.A. Share · BE0974280126 · A14NHV (XBRU) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of BONE THERAPEUTICSCS S.A.
No Price
Closing Price XBRU 30.04.2026: 0,002 EUR
30.04.2026 15:35
Current Prices from BONE THERAPEUTICSCS S.A.
ExchangeTickerCurrencyLast TradePriceDaily Change
XBRU: EURONEXT - EURONEXT BRUSSELS
EURONEXT - EURONEXT BRUSSELS
BIOS.BR
EUR
30.04.2026 15:35
0,002 EUR
0,00 EUR
XLON: London
London
0R55.L
EUR
30.04.2026 13:58
0,002 EUR
-
Share Float & Liquidity
Free Float 92,39 %
Shares Float 603,17 M
Shares Outstanding 652,86 M
Company Profile for BONE THERAPEUTICSCS S.A. Share
BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures. The company is based in Mont-Saint-Guibert, Belgium.

Company Data

Name BONE THERAPEUTICSCS S.A.
Company Bone Therapeutics S.A.
Website https://www.biosenic.com
Primary Exchange XBRU EURONEXT - EURONEXT BRUSSELS
WKN A14NHV
ISIN BE0974280126
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Miguel Forte
Country Belgium
Currency EUR
Employees 0,0 T
Address Rue Granbonpré 11 - Bâtiment H, 1435 Mont-Saint-Guibert
IPO Date 2015-02-06
Dividends from 'BONE THERAPEUTICSCS S.A.'
Ex-Date Dividend per Share
15.03.2022 0,29 EUR

Ticker Symbols

Name Symbol
EURONEXT - EURONEXT BRUSSELS BIOS.BR
EURONEXT - EURONEXT BRUSSELS BOTHE.BR
Frankfurt BT1.F
London 0R55.L
More Shares
Investors who hold BONE THERAPEUTICSCS S.A. also have the following shares in their portfolio:
Fidelity Freedom 2060 Fund
Fidelity Freedom 2060 Fund Fund
KINGMAN MINERALS LTD
KINGMAN MINERALS LTD Share